Alpha-1 adrenergic antagonists produce greater improvement in voiding symptoms and urinary flow rates than finasteride alone. No additive or synergistic effects have been proven when terazosin was ...

The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...